首頁 > 市場調查報告書 > 醫療設備

生技設備

蛋白質定序市場規模、佔有率及成長分析（按產品、應用、最終用戶和地區分類）－產業預測（2026-2033 年）

市場調查報告書

商品編碼

1897616

蛋白質定序市場規模、佔有率及成長分析（按產品、應用、最終用戶和地區分類）－產業預測（2026-2033 年）

Protein Sequencing Market Size, Share, and Growth Analysis, By Product (Protein Sequencing Products, Protein Sequencing Services), By Application (Biomarker Discovery, Protein Engineering Studies), By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，蛋白質定序市場價值將達到 13.9 億美元，到 2025 年將成長至 14.4 億美元，到 2033 年將成長至 18.9 億美元，在預測期（2026-2033 年）內複合年成長率為 3.5%。

蛋白質定序是一種利用質譜分析來確定胺基酸序列的先進技術，能夠更深入地了解蛋白質結構。這種高通量蛋白質體學方法在各個應用領域，尤其是在標靶藥物研發領域，正日益受到關注。生技和製藥公司對標靶藥物研發的日益重視是推動市場擴張的主要動力。此外，各國對蛋白質體學研究投入的不斷增加也促進了產業發展。藥物研發中對蛋白質生物標記的需求不斷成長，進一步刺激了市場需求。未來標靶藥物設計的進步以及基因工程領域的持續研究將繼續推動蛋白質定序技術的演進，為該領域的創新和發展創造巨大機會。

蛋白質定序市場促進因素

蛋白質定序市場的成長可歸因於臨床質譜技術的進步和分析方法的日益精細化。這些創新預計將顯著推動該領域的需求。此外，公共和私營機構對蛋白質體學研究投入的不斷增加也將對市場擴張起到關鍵的促進作用。隨著更多資源投入闡明蛋白質結構和功能的研究，市場有望受益於投資和關注的提升，從而促進其進一步發展。技術進步與資金支持的融合，正為蛋白質定序領域的蓬勃發展奠定基礎。

蛋白質定序市場限制因素

蛋白質定序市場的成長面臨許多挑戰，主要源自於基礎建設的高昂成本。熟練的研究人員和實驗室人員短缺，而他們對於執行高級定序任務至關重要，這構成了另一個障礙。此外，製備高純度蛋白質樣本的需求進一步增加了複雜性和成本，阻礙了市場的廣泛擴張。這些因素共同作用，極大地阻礙因素了市場的潛力，因為相關人員必須在管理最尖端科技投資的同時，應對資源分配和人才培養方面的複雜挑戰。

蛋白質定序市場趨勢

蛋白質定序市場正經歷顯著成長，這主要得益於蛋白質工程技術的進步以及對包括抗體和疫苗在內的創新生物製劑日益成長的需求。將非天然胺基酸引入特定位點進行精確偶聯，正在革新生物製藥的研發。轉譯後修飾技術的進步和菌株開發的改進，使得蛋白質產品的精準性得以提升，並加快了生物製藥的核准流程。這一趨勢反映了為滿足治療需求而向更先進的蛋白質工程方向發展的廣泛趨勢，為市場參與者在不斷變化的醫療保健環境中進行創新並提高藥物研發效率提供了盈利的機會。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Thermo Fisher Scientific Inc.（USA）
Agilent Technologies, Inc.（USA）
Bioinformatics Solutions Inc.（Canada）
Shimadzu Corporation（Japan）
Waters Corporation（USA）
Bruker Corporation（USA）
Danaher Corporation（USA）
PerkinElmer, Inc.（USA）
Charles River Laboratories International, Inc.（USA）
QIAGEN NV（Netherlands）
Merck KGaA（Germany）
GenScript Biotech Corporation（China）
Creative Proteomics（USA）
Bio-Rad Laboratories, Inc.（USA）
Promega Corporation（USA）
Pacific Biosciences of California, Inc.（USA）
Oxford Nanopore Technologies Ltd.（UK）
Illumina, Inc.（USA）
Becton, Dickinson and Company（USA）
Eurofins Scientific（Luxembourg）

結論與建議

簡介目錄

Product Code: SQSG35H2025

Protein Sequencing Market size was valued at USD 1.39 Billion in 2024 and is poised to grow from USD 1.44 Billion in 2025 to USD 1.89 Billion by 2033, growing at a CAGR of 3.5% during the forecast period (2026-2033).

Protein sequencing is an advanced technique that determines amino acid sequences through mass spectrometry, enhancing understanding of protein structures. This high-throughput proteomic method has gained traction across various applications, particularly in target-based drug discovery. The increasing emphasis on targeted medication development by biotechnology and pharmaceutical firms is a key driver of market expansion. Additionally, rising investments in proteomics research across different nations contribute to industry growth. The growing need for protein biomarkers in drug development further accelerates market demand. Anticipated advancements in target-based drug design and ongoing research in genetic engineering will continue to propel the evolution of protein sequencing technologies, creating significant opportunities for innovation and growth within the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Sequencing Market Segments Analysis

Global Protein Sequencing Market is segmented by product, application, end-user and region. Based on product, the market is segmented into protein sequencing products and protein sequencing services. Based on application, the market is segmented into biomarker discovery, protein engineering studies, biotherapeutics and others. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, research centers, academic institutions and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Protein Sequencing Market

The anticipated growth of the protein sequencing market can be attributed to advancements in clinical mass spectrometry and enhanced analytical techniques. These innovations are expected to significantly drive demand in the sector. Additionally, increased funding from both public and private organizations for proteomic research plays a crucial role in stimulating market expansion. As more resources are allocated towards understanding protein structures and functions, the market is likely to benefit from heightened investment and interest, further contributing to its development. This convergence of technological progress and financial backing sets the stage for a robust evolution in the protein sequencing landscape.

Restraints in the Protein Sequencing Market

The growth of the Protein Sequencing market faces significant challenges primarily due to the substantial costs associated with infrastructure. Furthermore, the limited availability of skilled researchers and laboratory personnel poses an additional barrier, as these professionals are essential for conducting advanced sequencing tasks. Moreover, the necessity of generating high-purity protein samples adds another layer of complexity and expense, hindering broader market expansion. These factors collectively create a formidable restraint on the market's potential, as stakeholders must navigate the complexities of resource allocation and personnel training while managing financial investments in cutting-edge technologies.

Market Trends of the Protein Sequencing Market

The Protein Sequencing market is experiencing a significant surge driven by advancements in protein engineering and the growing demand for innovative bioformulations, including antibodies and vaccines. The focus on incorporating unnatural amino acids for precise site-specific conjugation is revolutionizing the development of biopharmaceuticals. Enhanced post-translational engineering techniques and improved strain development are leading to better-defined protein products, facilitating expedited approval processes for biopharmaceuticals. This trend reflects a broader shift toward more sophisticated protein manipulation to meet therapeutic needs, presenting lucrative opportunities for market players to innovate and enhance drug development efficiency in the evolving healthcare landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies

Global Protein Sequencing Market Size by Product & Service & CAGR (2026-2033)

Market Overview
Protein Sequencing Products
- Reagents & Consumables
- Instruments
- Mass Spectrometry
- Edman Degradation
- Software
Protein Sequencing Services
- Sample Preparation Services
- Sequencing Services
- Data Analysis Services

Global Protein Sequencing Market Size by Application & CAGR (2026-2033)

Market Overview
Biomarker Discovery
Protein Engineering Studies
Biotherapeutics
Others
- Structural Biology
- Drug Discovery

Global Protein Sequencing Market Size by End-User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Research Centers
Academic Institutions
Others
- Contract Research Organizations (CROs)
- Diagnostic Laboratories

Global Protein Sequencing Market Size & CAGR (2026-2033)

North America (Product & Service, Application, End-User)
- US
- Canada
Europe (Product & Service, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Service, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Service, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Service, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioinformatics Solutions Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Proteomics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments